🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Deconstructing the molecular portraits of breast cancer

Aleix Prat, Charles M. Perou (2010)

Molecular Oncology

1.1K citesjournal articlePDF

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. Ducreux, A. Sa. Cuhna et al. (2015)

Annals of Oncology

1.1K citesjournal articlePDF

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

Quinn T. Ostrom, Haley Gittleman et al. (2016)

Neuro-Oncology

1.1K citesjournal articlePDF

Flat-panel cone-beam computed tomography for image-guided radiation therapy

David A Jaffray, Jeffrey H Siewerdsen et al. (2002)

International Journal of Radiation Oncology*Biology*Physics

1.1K citesjournal articlePDF

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams, Robert J. Gray et al. (2014)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

Rakesh K. Jain (2013)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Nanomaterials for cancer therapy: current progress and perspectives

Zhe Cheng, Maoyu Li et al. (2021)

Journal of Hematology & Oncology

1.1K citesjournal articlePDF

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

Deborah A. Kuban, Susan L. Tucker et al. (2008)

International Journal of Radiation Oncology*Biology*Physics

1.1K citesjournal articlePDF

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry et al. (2003)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

A. Schneeweiss, S. Chia et al. (2013)

Annals of Oncology

1.1K citesjournal articlePDF

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

Augusto Caraceni, Geoffrey Hanks et al. (2012)

The Lancet Oncology

1.1K citesjournal articlePDF

Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

Maura L. Gillison, Anil K. Chaturvedi et al. (2015)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Liquid biopsy enters the clinic — implementation issues and future challenges

Michail Ignatiadis, George W. Sledge et al. (2021)

Nature Reviews Clinical Oncology

1.1K citesjournal articlePDF

The PI3K Pathway As Drug Target in Human Cancer

Kevin D. Courtney, Ryan B. Corcoran et al. (2010)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

W. J. Curran, C. B. Scott et al. (1993)

JNCI Journal of the National Cancer Institute

1.0K citesjournal articlePDF